1. Home
  2. ARI vs SLDB Comparison

ARI vs SLDB Comparison

Compare ARI & SLDB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Apollo Commercial Real Estate Finance Inc

ARI

Apollo Commercial Real Estate Finance Inc

N/A

Current Price

$6.86

Market Cap

1.4B

Sector

Real Estate

ML Signal

N/A

Logo Solid Biosciences Inc.

SLDB

Solid Biosciences Inc.

N/A

Current Price

$49.45

Market Cap

1.1B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ARI
SLDB
Founded
2009
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.4B
1.1B
IPO Year
2009
2017

Fundamental Metrics

Financial Performance
Metric
ARI
SLDB
Price
$6.86
$49.45
Analyst Decision
Buy
Strong Buy
Analyst Count
3
11
Target Price
$11.00
$16.36
AVG Volume (30 Days)
3.0M
876.6K
Earning Date
04-28-2026
05-12-2026
Dividend Yield
9.31%
N/A
EPS Growth
183.51
34.97
EPS
0.27
N/A
Revenue
$271,589,000.00
$8,094,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$25.52
N/A
Revenue Growth
N/A
N/A
52 Week Low
$6.43
$3.79
52 Week High
$11.24
$11.45

Technical Indicators

Market Signals
Indicator
ARI
SLDB
Relative Strength Index (RSI) 35.55 56.51
Support Level $6.43 $5.21
Resistance Level $7.00 $11.45
Average True Range (ATR) 0.11 0.43
MACD 0.14 0.06
Stochastic Oscillator 73.90 67.25

Price Performance

Historical Comparison
ARI
SLDB

About ARI Apollo Commercial Real Estate Finance Inc

Apollo Commercial Real Estate Finance Inc is a real estate investment trust that originates, invests in, acquires, and manages commercial first-mortgage loans, subordinate financings, commercial mortgage-backed securities, and other real estate-related debt investments. The subordinate loans and first-mortgage loans account for the vast majority of the portfolio on a cost basis. Property types include residential, retail, healthcare, office, mixed-use, hotel, industrial, multifamily, securities, and other, with residential properties and hotels representing the highest property value. More than a third of the properties are located in New York City, with the other properties located across other regions of the United States, as well as other countries.

About SLDB Solid Biosciences Inc.

Solid Biosciences Inc is a life sciences company focused on advancing a portfolio of current and future gene therapy candidates, including SGT-003 for the treatment of Duchenne muscular dystrophy, SGT-212 for the treatment of Friedreich's ataxia, SGT-501 for the treatment of catecholaminergic polymorphic ventricular tachycardia, SGT-601 for the treatment of TNNT2-mediated dilated cardiomyopathy, and additional assets for the treatment of genetic cardiac and neuromuscular diseases. The majority of its current programs are designed to treat these diseases with gene transfer products. The company operates in a single segment, developing treatments through gene therapy and other means for patients with neuromuscular and cardiac diseases.

Share on Social Networks: